WallStSmart

BlackRock ESG Capital Allocation Trust (ECAT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target

BlackRock ESG Capital Allocation Trust stock (ECAT) is currently trading at $13.64. BlackRock ESG Capital Allocation Trust PE ratio is 6.26. BlackRock ESG Capital Allocation Trust PS ratio (Price-to-Sales) is 6.19. WallStSmart rates ECAT as Sell.

  • ECAT PE ratio analysis and historical PE chart
  • ECAT PS ratio (Price-to-Sales) history and trend
  • ECAT intrinsic value — DCF, Graham Number, EPV models
  • ECAT stock price prediction 2025 2026 2027 2028 2029 2030
  • ECAT fair value vs current price
  • ECAT insider transactions and insider buying
  • Is ECAT undervalued or overvalued?
  • BlackRock ESG Capital Allocation Trust financial analysis — revenue, earnings, cash flow
  • ECAT Piotroski F-Score and Altman Z-Score
  • ECAT analyst price target and Smart Rating
ECAT

BlackRock ESG Capital Allocation Trust

NYSEFINANCIAL SERVICES
$13.64
$0.07 (0.52%)
52W$10.74
$15.21

📊 No data available

Try selecting a different time range

IV

ECAT Intrinsic Value Analysis for Value Investors

Benjamin Graham Formula · BlackRock ESG Capital Allocation Trust (ECAT)

Margin of Safety
-6.4%
Overvalued
ECAT Fair Value
$14.62
Graham Formula
Current Price
$13.64
$0.98 above fair value
Undervalued
Fair: $14.62
Overvalued
Price $13.64
Graham IV $14.62

ECAT trades at a modest 6% premium above its Graham fair value of $14.62. Consider waiting for a pullback.

Based on Benjamin Graham Formula. Growth rate capped at 25%. For informational purposes only. Not financial advice.

WallStSmart

Smart Analysis

BlackRock ESG Capital Allocation Trust (ECAT) · 4 metrics scored

Smart Score

26
out of 100
Grade: F
Avoid
Investment Rating

Category Performance

WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.

Investment Thesis

Strong fundamentals in price/book. Significant fundamental concerns warrant caution or avoidance.

BlackRock ESG Capital Allocation Trust (ECAT) Key Strengths (1)

Avg Score: 10.0/10
Price/BookValuation
0.8310/10

Trading below book value, meaning the market prices it less than net assets

Supporting Valuation Data

P/E Ratio
6.26
Undervalued
Trailing P/E
6.26
Undervalued

BlackRock ESG Capital Allocation Trust (ECAT) Areas to Watch (3)

Avg Score: 5.0/10
Price/SalesValuation
6.194/10

Premium valuation at 6.2x annual revenue

Market CapQuality
$1.34B5/10

Small-cap company with higher risk but more growth potential

Institutional Own.Quality
36.69%6/10

Moderate institutional interest at 36.69%

Supporting Valuation Data

Price/Sales (TTM)
6.19
Premium

BlackRock ESG Capital Allocation Trust (ECAT) Detailed Analysis Report

Overall Assessment

This company scores 26/100 in our Smart Analysis, earning a F grade. Out of 4 metrics analyzed, 1 register as strengths (avg 10.0/10) while 3 fall into concern territory (avg 5.0/10). The category breakdown reveals uneven performance, with some areas requiring attention.

The Bull Case

The strongest argument centers on Price/Book. Valuation metrics including Price/Book (0.83) suggest the stock is attractively priced.

The Bear Case

The primary concerns are Price/Sales, Market Cap, Institutional Own.. Some valuation metrics including Price/Sales (6.19) suggest expensive pricing.

Key Dynamics to Monitor

Three factors to monitor going forward. First, whether Price/Sales improves, as this is the primary drag on the overall score. Second, overall profitability trends. Third, top-line growth trajectory.

Risk Considerations

Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.

Bottom Line

Fundamental challenges outweigh strengths at current levels. Price/Sales and Market Cap are the primary drags. Consider waiting for meaningful improvement before committing capital.

Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.

ECAT Price-to-Sales(PS) Ratio Chart

Historical valuation based on market cap ÷ trailing 12-month revenue

ECAT's Price-to-Sales ratio of 6.19x trades 46% below its historical average of 11.4x (24th percentile). The current valuation is 72% below its historical high of 21.97x set in Dec 2021, and 14% above its historical low of 5.41x in Apr 2024.

Compare ECAT with Competitors

Top ASSET MANAGEMENT stocks by market cap

Compare any two stocks →

Insider Transactions

Loading insider activity...

About BlackRock ESG Capital Allocation Trust(ECAT)

Exchange

NYSE

Sector

FINANCIAL SERVICES

Industry

ASSET MANAGEMENT

Country

USA

BlackRock ESG Capital Allocation Trust (ECAT) is a specialized investment vehicle designed to create a diversified portfolio of equities and private investments focused on companies that prioritize superior environmental, social, and governance (ESG) practices. Managed by BlackRock, a global leader in investment management, ECAT aims to provide compelling risk-adjusted returns while adhering to sustainable investment principles. By combining in-depth research and a robust ESG integration framework, the Trust is positioned to meet the growing demand for responsible investing, ultimately striving for sustainable capital appreciation over the long term.